To enable the quality department and all other Riddell employees to effectively manage and streamline quality processes within the Riddell Centre of Cancer Immunotherapy (RCCI), the University of Calgary (UCalgary) plans to award a three-year contract to Bluecord Inc. for providing an Electronic Quality Management System platform for the Riddell Centre of Cancer Immunotherapy Biomanufacturing program.
Bluecord’s unique features enable efficient handling of all documents through its online platform specifically designed for cell therapy manufacturing. It ensures compliance with stringent regulatory standards (21 CFR), offering robust document control, real-time data tracking, and comprehensive audit trails. Bluecord's unique features include automated workflow management which could be customized as per the RCCI Biomanufacturing program, seamless integration with lab systems, and advanced analytics for process optimization. Its user-friendly interface and customizable dashboards enhance operational efficiency, making it an indispensable tool for quality assurance, quality control, and cell therapy production.
The University of Calgary requires a proven and mature solution that must meet all the requirements listed in the ACAN.
